Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Alamar Biosciences, Inc.NASDAQ: ALMR

Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026

Deferred revenue of $2.19M in Q2 FY2026

Q2 FY2026 deferred revenue was $2.19M.

Context

  • Deferred revenue amounted to 0.6% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.19M+4.0% QoQ
Last fiscal yearDec 2025
$470K-18.3% YoY
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-18.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
470K USD
Year-over-year change
-18.3%
1-year CAGR
-18.3%

Deferred Revenue vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's Jun 2026 deferred revenue of $2.19M is the 5th highest of the 9 companies compared; the peer median is $7.09M.
  • Deferred revenue amounts to 0.6% of total assets for ALMR, versus a peer median of 0.7%.
ALMR Competitors Peer median
Deferred Revenue for ALMR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TECHBio-Techne CorporationSep 2026$31.76M +4.3%+16.1%1.2%
TXG10x Genomics, Inc.Sep 2026$22.96M +3.7%+44.8%2.2%
PACBPacific Biosciences of California, Inc.Mar 2026$16.33M +7.1%—2.1%
LABStandard BioTools Inc.Mar 2026$13.84M -20.1%+39.2%2.2%
ALMRAlamar Biosciences, Inc.Jun 2026$2.19M ——0.6%
SEERSeer, Inc.Mar 2026$334K -19.1%+36.9%0.1%
QSIQuantum-Si incorporatedMar 2026$91K -41.3%—0.0%
TWSTTwist Bioscience CorporationSep 2026$0 -100.0%—0.0%
NAUTNautilus Biotechnology, Inc.Mar 2026$0 ——0.0%
Peer median (excluding ALMR) $7.09M-19.1%+38.0%0.7%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.